Clinical Trial Update: Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans [NA]

View source ↗

Summary

A completed clinical trial evaluated a web-based training program for educating physicians on interpreting Florbetapir-PET scans, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• AMYVID (Florbetapir F-18)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer Disease, Mild Cognitive Impairment | NA | Status: COMPLETED | Results posted: 2012-06-07